Early-stage coronary artery atherosclerosis patients in 4-year follow-up
 
More details
Hide details
1
Katedra i Klinika Kardiologii, Wydział Nauk o Zdrowiu w Katowicach, Śląski Uniwersytet Medyczny w Katowicach
 
 
Corresponding author
Józefa Dąbek   

Katedra i Klinika Kardiologii, Wydział Nauk o Zdrowiu w Katowicach, Śląski Uniwersytet Medyczny w Katowicach, ul. Ziołowa 47, 40-635 Katowice
 
 
Ann. Acad. Med. Siles. 2019;73:1-7
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Cardiovascular disease, induced mainly by atherosclerosis, is the leading global cause of morbidity and mortality. Atherosclerosis develops in early childhood and coronary artery atherosclerosis can be found in about 50% of young people. As a result a great deal of effort is made to detect and identify people at increased risk of cardiovascular complications. Implementing preventive principles can prevent disease progression and the development of complications. Subclinical atherosclerosis is an early stage of the disease with only minor lesions in coronary arteries. Strong evidence supports the association between subclinical atherosclerosis and increased risk of coronary artery disease, fatal and non-fatal myocardial infarction as well as symptomatic angina. The aim of the study was to investigate the medium-term outcomes of patients with early-stage coronary atherosclerosis.

Material and methods:
From the initial group of patients with early-stage coronary artery disease (n = 45; 100%), in which coronary angiography showed no or only minor atherosclerotic lesions and in which the coronary artery calcium score assessed with 64-raw multislice computed tomography was positive (CACS > 0), 29 persons (64.5%) were enrolled in the study.

Results:
In the analyzed group of patients, satisfactory general prognosis was found. There were no cardiovascular deaths or serious non-fatal cardiovascular events. In addition, a high level of compliance, regular use of recommended treatment and satisfactory control of comorbidities and risk factors during the 48-month follow-up were observed in the studied patients. Improvement in the advancement of angina symptoms was also seen.

Conclusions:
The subpopulation of patients with early-stage coronary artery disease is burdened with moderate cardio-vascular risk in an intermediate term observation.

REFERENCES (19)
1.
WHO Global status report on noncommunicable diseases. WHO (2014) [online], http://apps.who.int/iris/bitst....
 
2.
McGill H.C. Jr, McMahan C.A., Herderick E.E., Malcom G.T., Tracy R.E., Strong J.P. Origin of atherosclerosis in childhood and adolescence. Am. J. Clin. Nutr. 2000; 72 (5 Suppl): 1307S–1315S, doi: 10.1093/ajen/72.5.1307s.
 
3.
Marzilli M., Merz C.N., Boden W.E., Bonow R.O., Capozza P.G., Chilian W.M., DeMaria A.N., Guarini G., Huqi A., Morrone D., Patel M.R., Weintraub W.S. Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! J. Am. Coll. Cardiol. 2012; 60(11): 951–956, doi: 10.1016/j.jacc.2012.02.082.
 
4.
Budoff M.J., Achenbach S., Blumenthal R.S., Carr J.J., Goldin J.G., Greenland P., Guerci A.D., Lima J.A., Rader D.J., Rubin G.D., Shaw L.J., Wiegers S.E. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation 2006; 114(16): 1761–1791.
 
5.
Peters S.A., den Ruijter H.M., Bots M.L., Moons K.G. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review. Heart 2012; 98(3): 177–184, doi: 10.1136/heartjnl-2011-300747.
 
6.
Kuller L., Borthani N., Furberg C., Gardin J., Manolio T., O’Leary D., Psaty B., Robbins J. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am. J. Epidemiol. 1994; 139(12): 1164–1179.
 
7.
Schmermund A., Erbel R. Unstable Coronary Plaque and Its Relation to Coronary Calcium. Circulation 2001; 104(14): 1682–1687.
 
8.
Lubanski M.S., Vanhecke T.E., Chinnaiyan K.M., Franklin B.A., McCullough P.A. Subclinical coronary atherosclerosis identified by coronary computed tomographic angiography in asymptomatic morbidly obese patients. Heart Int. 2010; 5(2): e15, doi: 10.4081/hi.2010.e15.
 
9.
Bittner D.O., Klinghammer L., Marwan M., Schmid J., Layritz C., Hoffmann U., Achenbach S., Pflederer T. Influence of Cardiovascular Risk Factors on the Prevalence of Coronary Atherosclerosis in Patients with Angiographically Normal Coronary Arteries. Acad. Radiol. 2017; 24(5): 580–586, doi: 10.1016/j.acra.2016.12.005.
 
10.
Hoffmann A., Natoli G., Ghosh G. Transcriptional regulation via the NF-κB signaling module. Oncogene 2006; 25(51): 6706–6716.
 
11.
Kolodgie F.D., Burke A.P., Nakazawa G., Virmani R. Is Pathologic Intimal Thickening the Key to Understanding Early Plaque Progression in Human Atherosclerotic Disease? Arterioscler. Thromb. Vasc. Biol. 2007; 27(5): 986–989.
 
12.
Bild D.E., Bluemke D.A., Burke G.L., Detrano R., Diez Roux A.V., Folsom A.R., Greenland P., Jacob D.R. Jr, Kronmal R., Liu K., Nelson J.C., O’Leary D., Saad M.F., Shea S., Szklo M., Tracy R.P. Multi-ethnic study of atherosclerosis: objectives and design. Am. J. Epidemiol. 2002; 156(9): 871–881.
 
13.
Chow B.J., Small G., Yam Y., Chen L., McPherson R., Achenbach S., Al-Mallah M., Berman D.S., Budoff M.J., Cademartiri F., Callister T.Q., Chang H.J., Cheng V.Y. et al. Prognostic and therapeutic implications of statin and aspirin therapy in individuals with nonobstructive coronary artery disease: results from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: an InteRnational Multicenter registry) registry. Arterioscler. Thromb. Vasc. Biol. 2015; 35(4): 981–989, doi: 10.1161/ATVBAHA.114.304351.
 
14.
Shepherd J., Cobbe S.M., Ford I., Isles C.G., Lorimer A.R., MacFarlane P.W., McKillop J.H., Packard C.J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N. Engl. J. Med. 1995; 333(20): 1301–1307.
 
15.
Pedersen T.R., Kjekshus J., Berg K., Haghfelt T., Faergeman O., Faergeman G., Pyörälä K., Miettinen T., Wilhelmsen L., Olsson A.G., Wedel H. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. Atheroscler. Suppl. 2004; 5(3): 81–87.
 
16.
Min J.K., Dunning A., Lin F.Y., Achenbach S., Al-Mallah M., Budoff M.J., Cademartiri F., Callister T.Q., Chang H.J., Cheng V., Chinnaiyan K. i wsp. Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: an International Multicenter Registry) of 23,854 patients without known coronary artery disease. J. Am. Coll. Cardiol. 2011; 58(8): 849–860, doi: 10.1016/j.jacc.2011.02.074.
 
17.
Min J.K., Shaw L.J., Devereux R.B., Okin P.M., Weinsaft J.W., Russo D.J., Lippolis N.J., Berman D.S., Callister T.Q. Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. J. Am. Coll. Cardiol. 2007; 50(12): 1161–1170.
 
18.
Abdulla J., Asferg C., Kofoed K.F. Prognostic value of absence or presence of coronary artery disease determined by 64-slice computed tomography coronary angiography a systematic review and meta-analysis. Int. J. Cardiovasc. Imaging 2011; 27(3): 413–420, doi: 10.1007/s10554-010-9652-x.
 
19.
Piepoli M.F., Hoes A.W., Agewall S., Albus C., Brotons C., Catapano A.L., Cooney M.-T., Corrà U., Cosyns B., Deaton C., Graham I. i wsp. Wytyczne ESC dotyczące prewencji chorób układu sercowo-naczyniowego w praktyce klinicznej w 2016 roku. Kardiol. Pol. 2016; 74(9): 821–936, doi: 10.5603/KP.2016.0120.
 
eISSN:1734-025X
Journals System - logo
Scroll to top